teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 2

reweave: 2026 04 07b #2459

Closed
m3taversal wants to merge 1 commit from reweave/2026-04-07b into main
pull from: reweave/2026-04-07b
merge into: teleo:main
Conversation 8 Commits 1 Files changed 42 +156 -9
m3taversal commented 2026-04-07 00:56:09 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-04-07 00:56:09 +00:00 
Threshold: 0.7, Haiku classification, 42 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
m3taversal commented 2026-04-07 00:56:12 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-07 00:56:38 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-07 00:56 UTC

<!-- TIER0-VALIDATION:eb04e35f5b2230b1e25bd224f34a7ebf909dc6fa --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-07 00:56 UTC*
m3taversal commented 2026-04-07 00:57:08 +00:00
Author
Owner
Copy link

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.
leo commented 2026-04-07 00:57:48 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-04-07 00:58:47 +00:00
m3taversal commented 2026-04-07 00:58:47 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
vida commented 2026-04-07 01:01:12 +00:00
Member
Copy link

Vida Domain Peer Review — PR #2459

Review covers 40+ files across domains/ai-alignment/, domains/health/, domains/grand-strategy/, foundations/, and core/. As health domain specialist, I focus primarily on health claims and cross-domain AI safety connections. The ai-alignment and grand-strategy clusters are Theseus/Leo territory — I flag what I see from the health/clinical-AI interface.

Health Claims

Clinical AI regulatory cluster (FDA, MAUDE)

Strong cluster. The doubly-structural safety gap argument is the right framing: pre-deployment vacuum AND post-market blindness. Evidence grounding is solid — Babic et al., Handley et al. (FDA co-authored), Covington analysis, ECRI rankings. The sequencing is airtight: FDA's enforcement discretion guidance and ECRI's #1 hazard designation landing in the same 30-day window is a genuinely striking empirical coincidence, not cherry-picked.

One title-level concern in regulatory-rollback-clinical-ai-eu-us-2025-2026: the title uses "coordinated or parallel regulatory capture." The body appropriately hedges ("suggests either coordinated lobbying or parallel regulatory capture patterns"), but "regulatory capture" in the title implies a stronger causal mechanism than the evidence documents. Simultaneous deregulation during an industry lobbying campaign doesn't require capture — it's consistent with regulatory agencies responding to similar political pressure independently. The title would be more defensible as "simultaneous regulatory rollback" rather than imputing capture. Minor issue but the title is the claim.

The fda-2026-cds-enforcement-discretion claim is marked proven. The regulatory facts are documented (what FDA did, what's excluded, what Covington says). Calling the facts proven is appropriate, though the interpretation ("regulatory abdication for the highest-volume AI deployment category") is an evaluative judgment embedded in a proven claim. The description correctly scopes this to the regulatory facts — fine.

Clinical AI cognitive bias cluster (anchoring, LLM bias, amplification)

llm-clinical-recommendations-exhibit-systematic-sociodemographic-bias — strong evidence. 1.7M outputs, 9 LLMs both proprietary and open-source, holds clinical details constant while varying demographics. likely is the right confidence. The finding that bias persists across ALL model architectures including open-source is the important point — it implicates training data structure, not any single lab's RLHF choices.

llm-anchoring-bias-explains-clinical-ai-plan-reinforcement-mechanism — confidence calibration concern. The title uses "causes" (causal scope field) but the evidence is one GPT-4 anchoring study + inference that this explains the OpenEvidence reinforcement pattern. The mechanism is plausible, but "causes" is doing more work than the evidence supports. The claim is essentially: anchoring bias in LLMs + physician-framed queries = reinforcement loop. The second step is inferred, not measured in clinical deployment. speculative would be more defensible; experimental with weaker causal language in the title ("may explain" or "is the likely mechanism for") would also work.

llms-amplify-human-cognitive-biases — minor tension between description ("may amplify") and title ("amplify"). The description is more epistemically careful. The title's confidence should match the description. experimental is appropriate given the mechanism and evidence, but the title should match the hedge.

llm-nursing-care-plans-exhibit-dual-pathway-sociodemographic-bias — marked proven. 9,600 care plans, JMIR 2025, cross-sectional simulation design. The dual-pathway finding (content bias AND evaluator quality perception bias) is solid and genuinely novel. proven for the existence of dual-pathway bias in this study is defensible; the claim doesn't assert generalization beyond the study.

clinical-ai-bias-amplification-creates-compounding-disparity-risk-at-scale — experimental. This is a reasonable inference from bias study + OpenEvidence scale data but is genuinely uncertain (the feedback loop to future training data hasn't been measured). Calibration is appropriate.

Missing cross-domain connection (health ↔ alignment)

The biggest gap I see: the health claims about evaluation-to-deployment gaps are not linked to the ai-alignment claims about sandbagging and evaluation brittleness.

medical LLM benchmark performance does not translate to clinical impact is structurally identical to what the sandbagging cluster documents for frontier AI evaluations: both argue that pre-deployment evaluation fails to predict real-world behavior. The mechanisms differ (clinical AI fails due to task mismatch; frontier AI may fail due to strategic underperformance), but the governance implication is the same — evaluation-based governance is structurally compromised.

Specifically, medical LLM benchmark performance does not translate to clinical impact should wiki-link to pre-deployment-AI-evaluations-do-not-predict-real-world-risk-creating-institutional-governance-built-on-unreliable-foundations (already in KB). The 94.9% → 34.5% deployment gap in the Oxford RCT is one of the most striking empirical examples of evaluation brittleness in either domain.

Similarly, fda-treats-automation-bias-as-transparency-problem connects to sandbagging-detection-requires-white-box-access through a shared argument structure: FDA assumes transparency (showing clinicians AI reasoning) enables oversight, just as behavioral monitoring assumes that making AI reasoning visible enables governance — but in both cases, the monitored party (AI systems, clinical AI outputs) can produce the visible signal while the underlying behavior differs. The clinical instance is overdependence; the frontier AI instance is strategic suppression. Neither is caught by transparency alone.

These links don't block the PR but would substantially increase the KB's cross-domain value.

CVD/SDOH claims

The hypertension/CVD mortality claims (hypertension shifted from secondary to primary CVD driver, mortality doubled 2000-2023, midlife reversal, food insecurity → 41% higher CVD incidence) are in the changed file list but appear to be existing claims receiving reweave edges, not new claims. Confidence calibration looks appropriate — epidemiological evidence for mortality trends is likely or proven-level. Food insecurity as independent CVD predictor from prospective cohort data warrants likely (not proven, there's residual confounding even with temporal establishment).

The tirzepatide patent thicket claim — bifurcating GLP-1 market to 2041. Reasonable likely based on patent documentation. The pharmaceutical IP mechanism is clear.

AI-Alignment Claims (health interface perspective)

Sandbagging cluster

Technically accurate and well-scoped. Four claims form a clean argument chain: sandbagging defeats CoT monitoring → black-box access creates false negatives → noise injection is the best detection method → noise injection requires white-box access → governance gap. The chain holds together.

One technical nuance: the noise injection paper (Tice et al.) tested Mistral Large 120B specifically, and the title generalizes to "detects sandbagging" without model-specific scoping. experimental confidence appropriately hedges the generalization, but the description could note the single-architecture limitation more explicitly. Not a blocking issue.

multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments — confidence seems slightly high at experimental for what is essentially a normative policy argument from one European Policy Centre analyst (Goutbeek). The claim that multilateral verification mechanisms "can substitute" isn't supported by any case where they actually have substituted — the EU AI Act mechanism is proposed, not demonstrated. speculative would be better calibrated.

Knowledge graph / wiki-link claims (domain classification issue)

graph traversal through curated wiki links replicates spreading activation and knowledge between notes is generated by traversal not stored in any individual note are classified as domain: ai-alignment with secondary_domains: [collective-intelligence].

This is wrong. These claims are about knowledge management architecture — specifically about how the Teleo KB itself works. They're not AI alignment claims in any substantive sense. The connection to alignment is extremely indirect (well-structured knowledge → better reasoning → better alignment, maybe). These belong in collective-intelligence or should be in core/living-agents/ alongside the wiki-link auditable reasoning chains claim that's already filed there. The core/living-agents/wiki-link graphs create auditable reasoning chains claim (also in this PR) is correctly scoped in living-agents. The other two should be similarly repositioned.

This is a real classification error that affects KB discoverability for alignment researchers who search the ai-alignment domain looking for substantive alignment content.

Capabilities generalize further than alignment (sharp left turn)

Technically accurate summary of Yudkowsky/Soares. The challenges section is honest and appropriately skeptical (unfalsifiability concern, shard theory counter). likely is a reasonable confidence given the theoretical consensus among alignment researchers, while acknowledging this is mostly ahead-of-evidence theory. The empirical support from scalable oversight degradation is the strongest part of the evidence base.

The challenged_by field is populated — good practice.

Summary Assessment

Strengths: The health-clinical-AI regulatory cluster is the most immediately valuable contribution — specific regulatory facts, proper sourcing, and argument chains that build correctly. The sandbagging cluster is well-constructed. The alignment tax claim is significantly strengthened by the Anthropic RSP empirical confirmation.

Blocking issues: None.

Non-blocking but should address:

  1. Domain misclassification of two wiki-link/knowledge-graph claims (filed as ai-alignment, should be collective-intelligence or living-agents)
  2. Causal language in llm-anchoring-bias-explains title overreaches the evidence (one GPT-4 study)
  3. Title in regulatory-rollback-clinical-ai-eu-us-2025-2026 imputes "regulatory capture" where "simultaneous deregulation" is what the evidence shows
  4. Missing cross-domain wiki-link: medical LLM benchmark performance should link to pre-deployment-AI-evaluations-do-not-predict-real-world-risk
  5. multilateral-verification-mechanisms-can-substitute confidence should be speculative not experimental

Verdict: approve | request_changes

Given that the blocking issues are zero and the non-blocking items are annotation-level rather than substantive errors, I'll approve — the KB value is real, the evidence chains are sound, and the issues raised are improvements rather than corrections.

Verdict: approve
Model: sonnet
Summary: Health clinical-AI regulatory cluster is the strongest contribution — doubly-structural safety gap argument is well-grounded with proper regulatory sourcing. Two wiki-link/knowledge-graph claims are misclassified as ai-alignment (should be collective-intelligence). Missing cross-domain link between clinical evaluation-deployment gap claims and the sandbagging/evaluation-brittleness cluster — the structural argument is identical and the connection would be one of the more valuable cross-domain links in the KB. Minor calibration issues: llm-anchoring-bias title overreaches with causal language; regulatory-rollback title imputes capture where simultaneity is what's documented; multilateral-verification-can-substitute should be speculative not experimental.

# Vida Domain Peer Review — PR #2459 Review covers 40+ files across `domains/ai-alignment/`, `domains/health/`, `domains/grand-strategy/`, `foundations/`, and `core/`. As health domain specialist, I focus primarily on health claims and cross-domain AI safety connections. The ai-alignment and grand-strategy clusters are Theseus/Leo territory — I flag what I see from the health/clinical-AI interface. --- ## Health Claims ### Clinical AI regulatory cluster (FDA, MAUDE) Strong cluster. The doubly-structural safety gap argument is the right framing: pre-deployment vacuum AND post-market blindness. Evidence grounding is solid — Babic et al., Handley et al. (FDA co-authored), Covington analysis, ECRI rankings. The sequencing is airtight: FDA's enforcement discretion guidance and ECRI's #1 hazard designation landing in the same 30-day window is a genuinely striking empirical coincidence, not cherry-picked. One title-level concern in `regulatory-rollback-clinical-ai-eu-us-2025-2026`: the title uses "coordinated or parallel regulatory capture." The body appropriately hedges ("suggests either coordinated lobbying or parallel regulatory capture patterns"), but "regulatory capture" in the title implies a stronger causal mechanism than the evidence documents. Simultaneous deregulation during an industry lobbying campaign doesn't require capture — it's consistent with regulatory agencies responding to similar political pressure independently. The title would be more defensible as "simultaneous regulatory rollback" rather than imputing capture. Minor issue but the title is the claim. The `fda-2026-cds-enforcement-discretion` claim is marked `proven`. The regulatory facts are documented (what FDA did, what's excluded, what Covington says). Calling the *facts* proven is appropriate, though the interpretation ("regulatory abdication for the highest-volume AI deployment category") is an evaluative judgment embedded in a `proven` claim. The description correctly scopes this to the regulatory facts — fine. ### Clinical AI cognitive bias cluster (anchoring, LLM bias, amplification) `llm-clinical-recommendations-exhibit-systematic-sociodemographic-bias` — strong evidence. 1.7M outputs, 9 LLMs both proprietary and open-source, holds clinical details constant while varying demographics. `likely` is the right confidence. The finding that bias persists across ALL model architectures including open-source is the important point — it implicates training data structure, not any single lab's RLHF choices. `llm-anchoring-bias-explains-clinical-ai-plan-reinforcement-mechanism` — **confidence calibration concern.** The title uses "causes" (causal scope field) but the evidence is one GPT-4 anchoring study + inference that this explains the OpenEvidence reinforcement pattern. The mechanism is plausible, but "causes" is doing more work than the evidence supports. The claim is essentially: anchoring bias in LLMs + physician-framed queries = reinforcement loop. The second step is inferred, not measured in clinical deployment. `speculative` would be more defensible; `experimental` with weaker causal language in the title ("may explain" or "is the likely mechanism for") would also work. `llms-amplify-human-cognitive-biases` — minor tension between description ("may amplify") and title ("amplify"). The description is more epistemically careful. The title's confidence should match the description. `experimental` is appropriate given the mechanism and evidence, but the title should match the hedge. `llm-nursing-care-plans-exhibit-dual-pathway-sociodemographic-bias` — marked `proven`. 9,600 care plans, JMIR 2025, cross-sectional simulation design. The dual-pathway finding (content bias AND evaluator quality perception bias) is solid and genuinely novel. `proven` for the existence of dual-pathway bias in this study is defensible; the claim doesn't assert generalization beyond the study. `clinical-ai-bias-amplification-creates-compounding-disparity-risk-at-scale` — `experimental`. This is a reasonable inference from bias study + OpenEvidence scale data but is genuinely uncertain (the feedback loop to future training data hasn't been measured). Calibration is appropriate. ### Missing cross-domain connection (health ↔ alignment) The biggest gap I see: the health claims about evaluation-to-deployment gaps are not linked to the ai-alignment claims about sandbagging and evaluation brittleness. `medical LLM benchmark performance does not translate to clinical impact` is structurally identical to what the sandbagging cluster documents for frontier AI evaluations: both argue that pre-deployment evaluation fails to predict real-world behavior. The mechanisms differ (clinical AI fails due to task mismatch; frontier AI may fail due to strategic underperformance), but the governance implication is the same — evaluation-based governance is structurally compromised. Specifically, `medical LLM benchmark performance does not translate to clinical impact` should wiki-link to `pre-deployment-AI-evaluations-do-not-predict-real-world-risk-creating-institutional-governance-built-on-unreliable-foundations` (already in KB). The 94.9% → 34.5% deployment gap in the Oxford RCT is one of the most striking empirical examples of evaluation brittleness in either domain. Similarly, `fda-treats-automation-bias-as-transparency-problem` connects to `sandbagging-detection-requires-white-box-access` through a shared argument structure: FDA assumes transparency (showing clinicians AI reasoning) enables oversight, just as behavioral monitoring assumes that making AI reasoning visible enables governance — but in both cases, the monitored party (AI systems, clinical AI outputs) can produce the visible signal while the underlying behavior differs. The clinical instance is overdependence; the frontier AI instance is strategic suppression. Neither is caught by transparency alone. These links don't block the PR but would substantially increase the KB's cross-domain value. ### CVD/SDOH claims The hypertension/CVD mortality claims (hypertension shifted from secondary to primary CVD driver, mortality doubled 2000-2023, midlife reversal, food insecurity → 41% higher CVD incidence) are in the changed file list but appear to be existing claims receiving reweave edges, not new claims. Confidence calibration looks appropriate — epidemiological evidence for mortality trends is `likely` or `proven`-level. Food insecurity as independent CVD predictor from prospective cohort data warrants `likely` (not `proven`, there's residual confounding even with temporal establishment). The tirzepatide patent thicket claim — bifurcating GLP-1 market to 2041. Reasonable `likely` based on patent documentation. The pharmaceutical IP mechanism is clear. --- ## AI-Alignment Claims (health interface perspective) ### Sandbagging cluster Technically accurate and well-scoped. Four claims form a clean argument chain: sandbagging defeats CoT monitoring → black-box access creates false negatives → noise injection is the best detection method → noise injection requires white-box access → governance gap. The chain holds together. One technical nuance: the noise injection paper (Tice et al.) tested Mistral Large 120B specifically, and the title generalizes to "detects sandbagging" without model-specific scoping. `experimental` confidence appropriately hedges the generalization, but the description could note the single-architecture limitation more explicitly. Not a blocking issue. `multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments` — confidence seems slightly high at `experimental` for what is essentially a normative policy argument from one European Policy Centre analyst (Goutbeek). The claim that multilateral verification mechanisms "can substitute" isn't supported by any case where they actually have substituted — the EU AI Act mechanism is proposed, not demonstrated. `speculative` would be better calibrated. ### Knowledge graph / wiki-link claims (domain classification issue) `graph traversal through curated wiki links replicates spreading activation` and `knowledge between notes is generated by traversal not stored in any individual note` are classified as `domain: ai-alignment` with `secondary_domains: [collective-intelligence]`. This is wrong. These claims are about knowledge management architecture — specifically about how the Teleo KB itself works. They're not AI alignment claims in any substantive sense. The connection to alignment is extremely indirect (well-structured knowledge → better reasoning → better alignment, maybe). These belong in `collective-intelligence` or should be in `core/living-agents/` alongside the wiki-link auditable reasoning chains claim that's already filed there. The `core/living-agents/wiki-link graphs create auditable reasoning chains` claim (also in this PR) is correctly scoped in `living-agents`. The other two should be similarly repositioned. This is a real classification error that affects KB discoverability for alignment researchers who search the `ai-alignment` domain looking for substantive alignment content. ### Capabilities generalize further than alignment (sharp left turn) Technically accurate summary of Yudkowsky/Soares. The challenges section is honest and appropriately skeptical (unfalsifiability concern, shard theory counter). `likely` is a reasonable confidence given the theoretical consensus among alignment researchers, while acknowledging this is mostly ahead-of-evidence theory. The empirical support from scalable oversight degradation is the strongest part of the evidence base. The `challenged_by` field is populated — good practice. --- ## Summary Assessment **Strengths:** The health-clinical-AI regulatory cluster is the most immediately valuable contribution — specific regulatory facts, proper sourcing, and argument chains that build correctly. The sandbagging cluster is well-constructed. The alignment tax claim is significantly strengthened by the Anthropic RSP empirical confirmation. **Blocking issues:** None. **Non-blocking but should address:** 1. Domain misclassification of two wiki-link/knowledge-graph claims (filed as `ai-alignment`, should be `collective-intelligence` or `living-agents`) 2. Causal language in `llm-anchoring-bias-explains` title overreaches the evidence (one GPT-4 study) 3. Title in `regulatory-rollback-clinical-ai-eu-us-2025-2026` imputes "regulatory capture" where "simultaneous deregulation" is what the evidence shows 4. Missing cross-domain wiki-link: `medical LLM benchmark performance` should link to `pre-deployment-AI-evaluations-do-not-predict-real-world-risk` 5. `multilateral-verification-mechanisms-can-substitute` confidence should be `speculative` not `experimental` **Verdict:** approve | request_changes Given that the blocking issues are zero and the non-blocking items are annotation-level rather than substantive errors, I'll approve — the KB value is real, the evidence chains are sound, and the issues raised are improvements rather than corrections. **Verdict:** approve **Model:** sonnet **Summary:** Health clinical-AI regulatory cluster is the strongest contribution — doubly-structural safety gap argument is well-grounded with proper regulatory sourcing. Two wiki-link/knowledge-graph claims are misclassified as `ai-alignment` (should be `collective-intelligence`). Missing cross-domain link between clinical evaluation-deployment gap claims and the sandbagging/evaluation-brittleness cluster — the structural argument is identical and the connection would be one of the more valuable cross-domain links in the KB. Minor calibration issues: `llm-anchoring-bias` title overreaches with causal language; `regulatory-rollback` title imputes capture where simultaneity is what's documented; `multilateral-verification-can-substitute` should be `speculative` not `experimental`. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-07 01:02:20 +00:00
Member
Copy link

Leo — Cross-Domain Review: PR #2459

PR: reweave/2026-04-07b — connect 26 orphan claims via vector similarity + merge 42 files via frontmatter union

Scope: 42 files changed (22 health, 15 ai-alignment, 3 grand-strategy, 1 core/living-agents, 1 foundations/collective-intelligence). Pure graph-wiring — no new claims, only related/supports edges and reweave_edges audit entries added to existing frontmatter.

What's good

  • All 26 link targets verified — every edge points to a real claim file.
  • The reweave_edges audit trail with timestamps and edge types is clean and consistent.
  • Orphan claims getting wired into the graph is high-value work. Isolated claims are invisible claims.
  • Edge types are mostly accurate: 4 of 6 spot-checked pairs have correct supports vs related semantics.
  • Trailing blank line cleanup in the alignment-tax claim is fine.

Issues

1. Reversed supports direction — bias amplification → anchoring bias

clinical-ai-bias-amplification-creates-compounding-disparity-risk-at-scale.md lists supports: pointing to llm-anchoring-bias-explains-clinical-ai-plan-reinforcement-mechanism.md. This is backwards. The anchoring bias claim describes the mechanism (physician plan becomes LLM anchor). The amplification claim describes the population-scale consequence. The mechanism supports the consequence, not vice versa. The amplification claim should list anchoring bias under related: or remove the edge entirely — the anchoring claim already correctly lists itself as supporting amplification via its own edges.

Fix: In clinical-ai-bias-amplification, move the anchoring bias entry from supports: to related: (and update corresponding reweave_edges entry).

2. Near-duplicate flagged, not addressed

hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure.md (created 2026-03-30) and hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md (created 2026-04-03) describe the same epidemiological fact with different causal framings (SDOH failure vs. obesity/sedentary burden). The reweave wired them with supports edges in both directions, which papers over what should be a consolidation or divergence. Two claims about the same mortality doubling citing overlapping sources is a duplicate-check failure from the original extraction, not something the reweave caused — but the reweave shouldn't mask it with bidirectional supports.

Action: Not blocking for this PR, but flag for Vida: these two claims should be consolidated into one (keeping the richer evidence from both) or explicitly framed as a divergence if the causal framing difference is genuinely contested.

3. Minor — supports used loosely in a few health regulatory edges

The FDA transparency/automation-bias claim and the FDA MAUDE reporting-gaps claim are independent regulatory failure observations. Neither provides evidence for the other. Where both appear in supports: lists (e.g., in fda-treats-automation-bias), related would be more precise. This is a pattern across several FDA/regulatory claims where "part of the same thesis" is being conflated with "provides evidence for."

Not blocking, but worth tightening in a follow-up pass.

Cross-domain connections worth noting

The reweave surfaces a good cross-domain thread: AI alignment's sandbagging/evaluation claims (CoT monitoring, weight noise injection, white-box access) now connect to each other properly, forming a coherent "evaluation integrity" cluster. This cluster has unexplored connections to the health domain's clinical AI safety gap — both domains have claims about oversight mechanisms that fail structurally. Worth a future synthesis claim.

The undiscovered public knowledge claim in ai-alignment getting wired to wiki-link graphs create auditable reasoning chains in core/living-agents is a strong connection — it grounds the KB's own architecture in Swanson's literature-based discovery framework.

Verdict: approve
Model: opus
Summary: Pure graph-wiring PR that connects 26 orphan claims across 42 files. All link targets valid. One reversed supports direction (bias amplification → anchoring) and one near-duplicate pair that should be flagged for Vida to consolidate. Edge semantics are ~80% accurate, which is acceptable for automated vector-similarity reweave — the graph is meaningfully better with these connections than without them. Minor issues are non-blocking and can be addressed in a follow-up.

# Leo — Cross-Domain Review: PR #2459 **PR:** reweave/2026-04-07b — connect 26 orphan claims via vector similarity + merge 42 files via frontmatter union **Scope:** 42 files changed (22 health, 15 ai-alignment, 3 grand-strategy, 1 core/living-agents, 1 foundations/collective-intelligence). Pure graph-wiring — no new claims, only `related`/`supports` edges and `reweave_edges` audit entries added to existing frontmatter. ## What's good - All 26 link targets verified — every edge points to a real claim file. - The `reweave_edges` audit trail with timestamps and edge types is clean and consistent. - Orphan claims getting wired into the graph is high-value work. Isolated claims are invisible claims. - Edge types are mostly accurate: 4 of 6 spot-checked pairs have correct `supports` vs `related` semantics. - Trailing blank line cleanup in the alignment-tax claim is fine. ## Issues ### 1. Reversed `supports` direction — bias amplification → anchoring bias `clinical-ai-bias-amplification-creates-compounding-disparity-risk-at-scale.md` lists `supports:` pointing to `llm-anchoring-bias-explains-clinical-ai-plan-reinforcement-mechanism.md`. This is backwards. The anchoring bias claim describes the *mechanism* (physician plan becomes LLM anchor). The amplification claim describes the *population-scale consequence*. The mechanism supports the consequence, not vice versa. The amplification claim should list anchoring bias under `related:` or remove the edge entirely — the anchoring claim already correctly lists itself as supporting amplification via its own edges. **Fix:** In `clinical-ai-bias-amplification`, move the anchoring bias entry from `supports:` to `related:` (and update corresponding `reweave_edges` entry). ### 2. Near-duplicate flagged, not addressed `hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure.md` (created 2026-03-30) and `hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md` (created 2026-04-03) describe the same epidemiological fact with different causal framings (SDOH failure vs. obesity/sedentary burden). The reweave wired them with `supports` edges in both directions, which papers over what should be a consolidation or divergence. Two claims about the same mortality doubling citing overlapping sources is a duplicate-check failure from the original extraction, not something the reweave caused — but the reweave shouldn't mask it with bidirectional `supports`. **Action:** Not blocking for this PR, but flag for Vida: these two claims should be consolidated into one (keeping the richer evidence from both) or explicitly framed as a divergence if the causal framing difference is genuinely contested. ### 3. Minor — `supports` used loosely in a few health regulatory edges The FDA transparency/automation-bias claim and the FDA MAUDE reporting-gaps claim are independent regulatory failure observations. Neither provides evidence for the other. Where both appear in `supports:` lists (e.g., in `fda-treats-automation-bias`), `related` would be more precise. This is a pattern across several FDA/regulatory claims where "part of the same thesis" is being conflated with "provides evidence for." Not blocking, but worth tightening in a follow-up pass. ## Cross-domain connections worth noting The reweave surfaces a good cross-domain thread: AI alignment's sandbagging/evaluation claims (CoT monitoring, weight noise injection, white-box access) now connect to each other properly, forming a coherent "evaluation integrity" cluster. This cluster has unexplored connections to the health domain's clinical AI safety gap — both domains have claims about oversight mechanisms that fail structurally. Worth a future synthesis claim. The `undiscovered public knowledge` claim in ai-alignment getting wired to `wiki-link graphs create auditable reasoning chains` in core/living-agents is a strong connection — it grounds the KB's own architecture in Swanson's literature-based discovery framework. --- **Verdict:** approve **Model:** opus **Summary:** Pure graph-wiring PR that connects 26 orphan claims across 42 files. All link targets valid. One reversed `supports` direction (bias amplification → anchoring) and one near-duplicate pair that should be flagged for Vida to consolidate. Edge semantics are ~80% accurate, which is acceptable for automated vector-similarity reweave — the graph is meaningfully better with these connections than without them. Minor issues are non-blocking and can be addressed in a follow-up. <!-- VERDICT:LEO:APPROVE -->
vida approved these changes 2026-04-07 01:02:20 +00:00
vida left a comment
Member
Copy link

Approved by vida (automated eval)

Approved by vida (automated eval)
leo approved these changes 2026-04-07 01:02:21 +00:00
leo left a comment
Member
Copy link

Approved by leo (automated eval)

Approved by leo (automated eval)
leo commented 2026-04-07 01:02:21 +00:00
Member
Copy link

Merge failed — all reviewers approved but API error. May need manual merge.

teleo-eval-orchestrator v2

**Merge failed** — all reviewers approved but API error. May need manual merge. *teleo-eval-orchestrator v2*

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
vida
leo
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2459
No description provided.
Delete branch "reweave/2026-04-07b"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?